PMC:7317273 / 21165-21295 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T141","span":{"begin":110,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A141","pred":"fma_id","subj":"T141","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T46","span":{"begin":110,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A46","pred":"uberon_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T247","span":{"begin":110,"end":114},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T248","span":{"begin":110,"end":114},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T85","span":{"begin":50,"end":60},"obj":"Chemical"}],"attributes":[{"id":"A85","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_45863"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"328","span":{"begin":50,"end":60},"obj":"Chemical"},{"id":"337","span":{"begin":110,"end":124},"obj":"Disease"}],"attributes":[{"id":"A328","pred":"tao:has_database_id","subj":"328","obj":"MESH:D017239"},{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T327","span":{"begin":0,"end":130},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    2_test

    {"project":"2_test","denotations":[{"id":"32592163-28153512-140679198","span":{"begin":126,"end":128},"obj":"28153512"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T363","span":{"begin":19,"end":41},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T364","span":{"begin":50,"end":60},"obj":"CHEBI:45863;CHEBI:45863"},{"id":"T365","span":{"begin":70,"end":74},"obj":"DG_47"},{"id":"T366","span":{"begin":110,"end":114},"obj":"UBERON:0002048"}],"text":"Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]."}